W.D. Whybrew

677 total citations
28 papers, 515 citations indexed

About

W.D. Whybrew is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology. According to data from OpenAlex, W.D. Whybrew has authored 28 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Obstetrics and Gynecology. Recurrent topics in W.D. Whybrew's work include Pregnancy and preeclampsia studies (8 papers), Neonatal Respiratory Health Research (6 papers) and Congenital Diaphragmatic Hernia Studies (4 papers). W.D. Whybrew is often cited by papers focused on Pregnancy and preeclampsia studies (8 papers), Neonatal Respiratory Health Research (6 papers) and Congenital Diaphragmatic Hernia Studies (4 papers). W.D. Whybrew collaborates with scholars based in United States. W.D. Whybrew's co-authors include E.T. Bucovaz, John C. Morrison, Baha M. Sibai, Winfred L. Wiser, Stewart A. Fish, Jack Schneider, John R. Barton, Robert A. Ahokas, Donald A. Wilson and Brian M. Mercer and has published in prestigious journals such as Biochemistry, Biochemical and Biophysical Research Communications and American Journal of Obstetrics and Gynecology.

In The Last Decade

W.D. Whybrew

27 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.D. Whybrew United States 12 239 169 167 119 105 28 515
Peter C. Buchan United Kingdom 10 115 0.5× 101 0.6× 128 0.8× 41 0.3× 37 0.4× 18 369
George H. Nelson United States 14 160 0.7× 206 1.2× 232 1.4× 31 0.3× 151 1.4× 44 514
L Viinikka Finland 11 99 0.4× 128 0.8× 30 0.2× 76 0.6× 31 0.3× 20 394
Mark Sivakoff United States 13 122 0.5× 97 0.6× 134 0.8× 29 0.2× 126 1.2× 23 635
Harry H. Gordon United States 16 168 0.7× 53 0.3× 114 0.7× 24 0.2× 71 0.7× 40 612
Dolores Moyano Spain 8 365 1.5× 303 1.8× 138 0.8× 42 0.4× 91 0.9× 11 660
Rafaella Cristhine Pordeus Luna Brazil 12 157 0.7× 248 1.5× 31 0.2× 69 0.6× 156 1.5× 29 573
R. Niththyananthan United Kingdom 14 98 0.4× 83 0.5× 28 0.2× 375 3.2× 85 0.8× 18 1.1k
Mary O'Halloran Australia 10 115 0.5× 19 0.1× 131 0.8× 42 0.4× 104 1.0× 27 471
Christine Houlihan Australia 13 82 0.3× 125 0.7× 35 0.2× 89 0.7× 69 0.7× 25 660

Countries citing papers authored by W.D. Whybrew

Since Specialization
Citations

This map shows the geographic impact of W.D. Whybrew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.D. Whybrew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.D. Whybrew more than expected).

Fields of papers citing papers by W.D. Whybrew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.D. Whybrew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.D. Whybrew. The network helps show where W.D. Whybrew may publish in the future.

Co-authorship network of co-authors of W.D. Whybrew

This figure shows the co-authorship network connecting the top 25 collaborators of W.D. Whybrew. A scholar is included among the top collaborators of W.D. Whybrew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.D. Whybrew. W.D. Whybrew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bucovaz, E.T., Robert M. MacLeod, John C. Morrison, & W.D. Whybrew. (1997). The coenzyme A-synthesizing protein complex and its proposed role in CoA biosynthesis in baker's yeast. Biochimie. 79(12). 787–798. 17 indexed citations
2.
Barton, J R, Baha M. Sibai, W.D. Whybrew, & B.M. Mercer. (1993). Urinary endothelin-1: Not a useful marker for preeclampsia. American Journal of Obstetrics and Gynecology. 168(2). 599–601. 10 indexed citations
3.
Whybrew, W.D., et al.. (1992). Oral Nifedipine Pharmacokinetics in Pregnancy‐Induced Hypertension. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 12(3). 174–177. 69 indexed citations
4.
Barton, John R., Baha M. Sibai, Robert A. Ahokas, W.D. Whybrew, & Brian M. Mercer. (1992). Magnesium sulfate therapy in preeclampsia is associated with increased urinary cyclic guanosine monophosphate excretion. American Journal of Obstetrics and Gynecology. 167(4). 931–934. 29 indexed citations
5.
Barton, John R., et al.. (1991). Nifedipine pharmacokinetics and pharmacodynamics during the immediate postpartum period in patients with preeclampsia. American Journal of Obstetrics and Gynecology. 165(4). 951–954. 32 indexed citations
6.
Sibai, Baha M., et al.. (1990). Labetalol pharmacokinetics in pregnancy-induced hypertension. American Journal of Obstetrics and Gynecology. 162(2). 362–366. 58 indexed citations
7.
McGehee, Ramon, et al.. (1988). Evaluation of the B-protein assay in cancer management. American Journal of Obstetrics and Gynecology. 158(4). 960–963. 2 indexed citations
8.
Lipshitz, Jeffrey, W.D. Whybrew, & Garland D. Anderson. (1984). Comparison of the Lumadex-foam stability index test, lecithin: sphingomyelin ratio, and simple shake test for fetal lung maturity.. PubMed. 63(3). 349–54. 8 indexed citations
9.
Lipshitz, Jeffrey, et al.. (1982). Placental transfer of 14C-hexoprenaline. American Journal of Obstetrics and Gynecology. 142(3). 313–315. 3 indexed citations
10.
Lipshitz, Jeffrey, et al.. (1981). Effects of hexoprenaline on the lecithin/sphingomyelin ratio and pressure-volume relationships in fetal rabbits. American Journal of Obstetrics and Gynecology. 139(6). 726–734. 3 indexed citations
11.
Morrison, John C., W.D. Whybrew, & E.T. Bucovaz. (1978). Use of partial exchange transfusion preoperatively in patients with sickle cell hemoglobinopathies. American Journal of Obstetrics and Gynecology. 132(1). 59–63. 32 indexed citations
12.
Morrison, John C., W.D. Whybrew, E.T. Bucovaz, & Jack Schneider. (1978). Injection of corticosteroids into mother to prevent neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology. 131(4). 358–366. 65 indexed citations
13.
Whybrew, W.D., et al.. (1978). The L/S ratio and shake test in normal and abnormal pregnancies.. PubMed. 52(4). 410–4. 5 indexed citations
14.
Morrison, John C., et al.. (1978). Cellular properties of the coenzyme A-synthesizing protein complex of Bakers' yeast. Life Sciences. 23(27-28). 2757–2767. 4 indexed citations
15.
Whybrew, W.D., et al.. (1977). Benign hemangiomyoma of the uterus.. PubMed. 49(1 suppl). 38–40. 9 indexed citations
16.
Morrison, John C., W.D. Whybrew, E.T. Bucovaz, Winfred L. Wiser, & Stewart A. Fish. (1977). The lecithin/sphingomyelin ratio in cases associated with fetomaternal disease. American Journal of Obstetrics and Gynecology. 127(4). 363–368. 26 indexed citations
17.
Morrison, John C., W.D. Whybrew, E.T. Bucovaz, & Winfred L. Wiser. (1976). Fluctuation of fetal hemoglobin in sickle-cell anemia. American Journal of Obstetrics and Gynecology. 125(8). 1085–1088. 10 indexed citations
18.
Morrison, John C., et al.. (1976). Metabolites of meperidine in the fetal and maternal serum. American Journal of Obstetrics and Gynecology. 126(8). 997–1002. 23 indexed citations
19.
Morrison, John C., et al.. (1974). Modification of the lecithin/sphingomyelin assay for fetal development. American Journal of Obstetrics and Gynecology. 120(8). 1087–1091. 10 indexed citations
20.
Morrison, John C., et al.. (1973). Metabolites of meperidine related to fetal depression. American Journal of Obstetrics and Gynecology. 115(8). 1132–1137. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026